Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
Author(s) -
Louise Bowman,
Marion Mafham,
Karl Wallendszus,
W. Grant Stevens,
Georgina Buck,
Jill Barton,
Kevin Murphy,
Theingi Aung,
Richard Haynes,
Jolyon Cox,
Aleksandra Murawska,
Allen J. Young,
Michael Lay,
Fang Chen,
Emily Sammons,
Emma Waters,
Amanda I Adler,
Jonathan Bodansky,
Andrew Farmer,
R. Kirk McPherson,
Andrew Neil,
David Simpson,
Richárd Pető,
Colin Baigent,
Rory Collins,
Sarah Parish,
Jane Armitage
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1804989
Subject(s) - diabetes mellitus , observational study , medicine , fatty acid , omega 3 fatty acid , randomized controlled trial , disease , endocrinology , gastroenterology , polyunsaturated fatty acid , biochemistry , docosahexaenoic acid , biology
Increased intake of n-3 fatty acids has been associated with a reduced risk of cardiovascular disease in observational studies, but this finding has not been confirmed in randomized trials. It remains unclear whether n-3 (also called omega-3) fatty acid supplementation has cardiovascular benefit in patients with diabetes mellitus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom